The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Resistance Training and Hydrolyzed Collagen Supplementation in Healthy Young Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06372080
Recruitment Status : Completed
First Posted : April 17, 2024
Last Update Posted : April 17, 2024
Sponsor:
Information provided by (Responsible Party):
Liverpool John Moores University

Tracking Information
First Submitted Date  ICMJE April 3, 2024
First Posted Date  ICMJE April 17, 2024
Last Update Posted Date April 17, 2024
Actual Study Start Date  ICMJE January 6, 2020
Actual Primary Completion Date September 29, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: April 12, 2024)
  • Maximal knee extensor (quadriceps) muscle strength [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for assessments) ]
    Using isokinetic dynamometer, knee extensor maximal isometric voluntary contraction torque (in Newton meters) will be measured.
  • Maximal knee flexor (hamstring) muscle strength [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) ]
    Using an isokinetic dynamometer, knee flexor maximal isometric voluntary contraction torque (in Newton meters) will be measured.
  • Patellar tendon cross-sectional area [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) ]
    Using ultrasonography, patellar tendon cross-sectional area (in millimeters squared) will be measured.
  • Patellar tendon stiffness [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) ]
    Using ultrasonography, patellar tendon stiffness (in Newtons per millimeter) will be measured.
  • Vastus lateralis (VL) muscle size [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) ]
    Using ultrasonography, the VL anatomical cross-sectional area (in centimeters squared) will be measured.
  • Vastus lateralis (VL) muscle fascicle length [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) ]
    Using ultrasonography, VL muscle fascicle length (in millimeters) will be measured.
  • Vastus lateralis (VL) muscle fascicle pennation angle [ Time Frame: 12 weeks (10 weeks' intervention plus one week either side for pre- and post-intervention assessments) ]
    Using ultrasonography, VL muscle fascicle pennation angle (in degrees) will be measured.
Original Primary Outcome Measures  ICMJE Same as current
Change History No Changes Posted
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Resistance Training and Hydrolyzed Collagen Supplementation in Healthy Young Adults
Official Title  ICMJE The Effects of Resistance Training With Hydrolyzed Collagen Supplementation on Muscle and Tendon Adaptation in Healthy Young Adults
Brief Summary

The goal of this clinical trial is to investigate the effects of resistance training with hydrolyzed collagen ingestion on changes in muscle and tendon adaptation in healthy young men and women.

The main questions it aims to answer are:

  • Does resistance training with hydrolyzed collagen ingestion lead to greater changes in tendon properties than resistance training alone?
  • Does resistance training with hydrolyzed collagen ingestion lead to greater changes in muscle size than resistance training alone?

Participants will be randomly assigned to collagen or placebo groups. Participants will perform resistance training three times per week for 10 weeks and hydrolyzed collagen or maltodextrin will be given to collagen or placebo group respectively immediately before each resistance training session. Also, vitamin C will be given to both groups.

Researchers will compare collagen and placebo groups to see if hydrolyzed collagen ingestion with resistance exercise would have beneficial effects on changes in muscle and tendon more than resistance training alone. Therefore, using isokinetic dynamometer and ultrasonography, maximal leg strength, morphological, mechanical, and material properties of the patellar tendon and vastus lateralis muscle size and architecture will be assessed.

Detailed Description

Young, healthy, active men and women will ingest 30 grams of hydrolyzed collagen or a calorie matched beverage (maltodextrin) alongside vitamin C prior to performing high-intensity resistance training 2 - 3 times per week for 10 weeks.

The aim of this study is to investigate the effect of combining hydrolyzed collagen supplementation with resistance training in young men and women. If supplementation with hydrolyzed collagen leads to a greater change in tendon size, stiffness, and Young's modulus than resistance training alone, this will allow us to recommend this type of intervention to young athletes seeking to improve tendon health and/or athletic performance.

The experimental design and measurements will be the same in the Arm 1 and Arm 2 but the differences will be sex where participants in Arm 1 will be healthy young men while participants in Arm 2 will be healthy young women.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:
The study design is a single-blind (participants were unaware of their group allocation), randomized controlled trial.
Masking: Single (Participant)
Primary Purpose: Basic Science
Condition  ICMJE
  • Healthy Participants
  • Nutrition
  • Exercise Training
Intervention  ICMJE
  • Dietary Supplement: Resistance training with hydrolyzed collagen ingestion in healthy young men

    Participants in this intervention will be healthy young men. The information of nutritional supplements is below.

    Hydrolyzed collagen: 30 grams unflavored hydrolysed collagen (HC) (Myprotein, Cheshire, UK) 30.5 grams unflavored maltodextrin (Myprotein, Cheshire, UK) 50 milligrams vitamin C powder (Holland and Barrett Retail Limited, Warwickshire, UK) 3 grams non-caloric sweetener (Truvia®, SilverSpoon, London, UK)

  • Dietary Supplement: Resistance training with hydrolyzed collagen ingestion in healthy young women
    Participants in this intervention will be healthy young women. The same nutritional supplements in Arm 1 wil be used in Arm 2.
Study Arms  ICMJE
  • Experimental: Resistance training with hydrolyzed collagen ingestion in healthy young men

    Healthy young men, pair-matched by age, body mass, height, and baseline strength, will be randomly allocated to the collagen (COL) or placebo (PLA) group.

    Pre- and post-training assessments are patellar tendon properties, maximal knee flexor and extensor strengths and vastus lateralis muscle morphology using an isokinetic dynamometer and ultrasound scan.

    Participants will perform the 10-week progressive resistance training program three times per week and training loads will be adjusted weekly based on the prior session's performance.

    In each session, two different calorie-matched beverages were given immediately before the start of resistance training. 30 grams of hydrolyzed collagen (HC) and 30.5 grams of maltodextrin were used for COL and PLA respectively. HC or maltodextrin was mixed with 250 milliliters of water, 50 milligrams of vitamin C and 3 grams non-caloric sweetener which was used to mask flavour in an opaque bottle.

    Intervention: Dietary Supplement: Resistance training with hydrolyzed collagen ingestion in healthy young men
  • Experimental: Resistance training with hydrolyzed collagen ingestion in healthy young women
    The intervention procedure is the same as for Arm 1 except that the participants will be healthy young women (not men).
    Intervention: Dietary Supplement: Resistance training with hydrolyzed collagen ingestion in healthy young women
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Completed
Actual Enrollment  ICMJE
 (submitted: April 12, 2024)
23
Original Actual Enrollment  ICMJE Same as current
Actual Study Completion Date  ICMJE March 31, 2023
Actual Primary Completion Date September 29, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Healthy young male or female
  • No history of patellar tendon injuries in the past 6 months
  • No history of lower limb musculoskeletal injuries in the past 6 months
  • Non-smokers (including e-cigarettes)
  • Free from cardiovascular and metabolic diseases
  • Nullipara (a woman who has never given birth)

Exclusion Criteria:

  • Age less than 18 years or higher than 40 years
  • Being vegan or vegetarian (due to the mammalian source of collagen)
  • Consumption of nutritional supplementation that purportedly affects muscle-tendon adaptation or recovery (i.e. protein powder, vitamin C, collagen)
  • BMI over 30 kg/m2
  • Previous anterior cruciate ligament injury where the patellar tendon was used as a graft
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 39 Years   (Adult)
Accepts Healthy Volunteers  ICMJE Yes
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE United Kingdom
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT06372080
Other Study ID Numbers  ICMJE 19/SPS/054
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Current Responsible Party Liverpool John Moores University
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Liverpool John Moores University
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account Liverpool John Moores University
Verification Date February 2024

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP